Searched for
NCES
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...23 May, 2026, 10.24 PM IST- PM Modi may inaugurate Phase 2 and Phase 3 of NCES in Varanasi city during his Oct 20 visitPrime Minister Narendra Modi is scheduled to inaugurate Phases 2 and 3 of the National Centre of Excellence Stadium in Varanasi on October ...16 Oct, 2024, 06.57 PM IST
- Zydus bets big on proprietary drugs to boost revenueSharvil Patel, managing director of Zydus Lifesciences said, half of the research and development (R&D) allocation is geared towards develo...03 Nov, 2023, 12.43 AM IST
- Wockhardt sets up its first manufacturing facility in Middle East"With the new facility in the Middle East, we aim to focus on our commitment to developing NCEs to fight the health issues," Wockhardt Foun...30 Jul, 2018, 01.30 PM IST
- Suven Life gets patents from Norway, South Korea, SingaporeThe granted claims pertain to new chemical entities (NCEs) developed by the firm to treat disorders associated with neurodegenerative disea...22 Mar, 2018, 12.30 PM IST
- Suven Life gets patent from New Zealand for neurological drugSuven Life said it has been granted "one product patent from New Zealand corresponding to the NCEs for the treatment of disorders associate...10 Oct, 2017, 11.50 AM IST
- Suven Life secures neuro drug patent from AustraliaThe company has been granted one product patent from Australia corresponding to the (NCEs) for the treatment of disorders associated with n...21 Jul, 2017, 02.10 PM IST
- Suven Life up 5% on patents for neuro-degenerative drugThe company was granted patents from Europe and Israel corresponding to the NCEs for the treatment of disorders associated with neuro-degen...18 Oct, 2016, 01.32 PM IST
- Suven Life Sciences gets patent for neuro-degenerative drugWith these new patents, Suven has a total of 23 granted patents from Australia and 22 from Canada.19 Feb, 2016, 12.06 PM IST
- Suven Life gets three patent approvals for CNS moleculesDrug firm Suven Life Sciences today said it has received three product patents for CNS molecules, two from Eurasia and one from Canada.31 Dec, 2012, 04.49 PM IST
- Suven Life sciences gets four patent approvals for CNS moleculesSuven Life sciences today said it has received four product patents from different countries for its new chemical entities.26 May, 2011, 03.27 PM IST
- Piramal Life Sciences mulls Rs 200 cr investment in R&DPiramal Life Sciences, R&D arm of Piramal Group, is investing Rs 200 crore in next two year's period for its ambitious programme to discove...17 May, 2009, 09.57 AM IST
- Suven Life gets patents for 2 neurodegenerative NCEsSuven Life Sciences' two chemical entities for treatment of disorders associated with neurodegenerative diseases have received patents from...31 Oct, 2007, 12.42 PM IST
- Suven gets patents for 3 NCEs for neuro disorders in IndiaSuven Life Sciences has received product patents in India for three new chemical entities 208688, 208714 and 209540 for treatment of disord...23 Oct, 2007, 12.35 PM IST
- Ranbaxy to hive off R&D bizRanbaxy Laboratories is planning to hive off the research and development (R&D) of its new chemical entities (NCEs) into a separate company.04 Oct, 2007, 02.31 AM IST
- Mashelkar told to clarify stand on patents reportRA Mashelkar’s report on whether India erred on its patent law, is getting curiouser and curiouser.20 Mar, 2007, 03.24 AM IST
- Indian pharma cos close to blockbuster breakthroughIndian pharma majors may manage to market their first indi-genous "blockbuster drugs" or new chemical entities (NCEs) in the next four year...07 Nov, 2006, 01.37 AM IST
Load More
